Amelioration of established experimental autoimmune encephalomyelitis by an MHC anchor-substituted variant of proteolipid protein 139-151.
about
T cell recognition of weak ligands: roles of signaling, receptor number, and affinityDesign of glycopeptides used to investigate class II MHC binding and T-cell responses associated with autoimmune arthritisA GMCSF-neuroantigen fusion protein is a potent tolerogen in experimental autoimmune encephalomyelitis (EAE) that is associated with efficient targeting of neuroantigen to APCManipulating antigenic ligand strength to selectively target myelin-reactive CD4+ T cells in EAE.Low 2-dimensional CD4 T cell receptor affinity for myelin sets in motion delayed response kinetics.Pertussis toxin as an adjuvant suppresses the number and function of CD4+CD25+ T regulatory cells.Structure, size, and solubility of antigen arrays determines efficacy in experimental autoimmune encephalomyelitis.Codelivery of antigen and an immune cell adhesion inhibitor is necessary for efficacy of soluble antigen arrays in experimental autoimmune encephalomyelitisAbortive activation of CD4 T cell responses during competitive priming in vivoPeptide-based immunotherapy of experimental autoimmune encephalomyelitis without anaphylaxis.Specific immunotherapy modifies allergen-specific CD4(+) T-cell responses in an epitope-dependent manner.Taming the TCR: antigen-specific immunotherapeutic agents for autoimmune diseases.CD4⁺ T cells in chronic autoantigenic stimulation in MGUS, multiple myeloma and Waldenström's macroglobulinemia.A unique unresponsive CD4+ T cell phenotype post TCR antagonism.Destabilization of peptide:MHC interaction induces IL-2 resistant anergy in diabetogenic T cellsIdentification of an altered peptide ligand based on the endogenously presented, rheumatoid arthritis-associated, human cartilage glycoprotein-39(263-275) epitope: an MHC anchor variant peptide for immune modulation.Immunoregulatory effects of atorvastatin on experimental autoimmune myocarditis in Lewis rats.
P2860
Q24626152-C1D448A5-E0D2-45F6-A323-C714A09F40AEQ28741917-3801F9B2-AB24-409B-9876-83BF1866FB21Q33694528-059E6BA3-A510-4BA4-BA5C-F65A7EFF289FQ33838467-89E234A1-744B-4194-B73C-012C6CDA7E3BQ34193211-1CD40E4C-2731-47EB-AD41-1114A902140FQ35157701-A686C268-9FDF-4C9D-B05E-1C91C143C9F9Q35318199-C6403B19-57C2-49BA-8409-EF162A5AA484Q35571156-8CE4FACB-66CD-476A-A38D-154C576FBF3AQ37208979-81C6E778-0579-4A6B-9AE3-D52F0A427769Q37235161-472A293E-BA82-48CA-901F-B61F6D2D06C3Q37653072-77F06D29-16C3-4713-96C5-88F914D6C7F0Q38477340-1B02A8D8-234C-4C69-82A9-AD8157BC777CQ38910238-207311B0-D010-4C37-B65D-923647D5A4F2Q39611811-C4F9DD66-5F4E-4056-8965-A1A83791FE13Q41772561-8F41C0B6-D5C3-471F-83F7-B7FFD3FA01AAQ42963596-EEB20648-0333-444C-AD52-54A3D3E0367EQ46970256-134B7C68-307C-48B1-AA47-E678615838D2
P2860
Amelioration of established experimental autoimmune encephalomyelitis by an MHC anchor-substituted variant of proteolipid protein 139-151.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Amelioration of established ex ...... f proteolipid protein 139-151.
@en
type
label
Amelioration of established ex ...... f proteolipid protein 139-151.
@en
prefLabel
Amelioration of established ex ...... f proteolipid protein 139-151.
@en
P1476
Amelioration of established ex ...... f proteolipid protein 139-151.
@en
P2093
Carrie D Margot
Mandy L Ford
P304
P356
10.4049/JIMMUNOL.174.6.3352
P407
P577
2005-03-01T00:00:00Z